Organ and tissue donation is a race against time, where every second and every data point impacts a life. Traditional donor management systems are buckling under the weight of complexity and regulation, leading to critical inefficiencies and compliance risks.
Data is trapped in operational silos across a multitude of systems, documents, and images, leading to no single, unified system of record.
Manual processes by medical record review staff can be time consuming and error-prone, thus lead to elongated processing times and inefficiently sequenced production cycles.
Exhaustive, manual documentation for FDA, AATB, and CMS standards, draining staff time from the review process and increasing audit risk.
Our Donor Lifecycle Management platform uses the latest AI models and automation tools to track and manage human tissue, ensuring the safety and integrity of the gift of donation throughout its entire lifecycle.
Maintains a complete “Chain of Custody,” allowing for the precise tracking of tissue from the initial donor through processing and eventually to the medical facility or recipient.
Combined with our medical chart review tool, DNA Application, we help streamline the complex eligibility and suitability process
Centralizes data for better inventory, logistics, and production management of tissue components.
Dependable record-keeping system to ensure compliance with AATB and FDA/CMS standards.
Traditional systems are records repositories. Donor lifecycle management is a decision engine. It is purpose-built to manage the entire donor lifecycle, integrating AI (NLP, Computer Vision, and Predictive Analytics) to automate complex decision-making, ensure regulatory compliance, and provide objective quality assessment—tasks a standard EMR/LIS cannot perform.
Donor lifecycle management moves beyond simple risk calculators. By leveraging real-time data and sophisticated Bayesian models, it provides a dynamic probability score for both post-transplant success and the likelihood of an organ/tissue being unsuitable. This helps procurement teams make faster, more confident, and ultimately, better-informed decisions on the fly.
It means our Intelligent Donor Lifecycle Management system can link and de-duplicate donor records with industry-leading precision. For every 100 potential donors, we accurately identify and resolve records for 95 of them, compared to 78 in traditional systems. This dramatically reduces the risk of missed opportunities or accidental duplicate processing.
Our Computer Vision Quality Assessment module has achieved FDA Breakthrough Device Designation. This designation recognizes its potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions, confirming its significance in clinical quality assessment.
